COMMUNIQUÉS West-GlobeNewswire
-
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
20/07/2018 - 16:45 -
Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer
20/07/2018 - 16:30 -
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
20/07/2018 - 13:30 -
T2 Biosystems Announces 2018 Second Quarter Financial and Operational Results Release and Conference Call Date
20/07/2018 - 13:00 -
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
20/07/2018 - 15:10 -
Diversicare to Announce Second Quarter 2018 Financial Results on Thursday, August 2, 2018
20/07/2018 - 15:00 -
CV Sciences, Inc. to Host Second Quarter 2018 Financial Results Conference Call on Wednesday August 1, 2018
20/07/2018 - 14:45 -
Biogen to Host Investor Webcast to Discuss Alzheimer’s Disease Portfolio on July 25, 2018
20/07/2018 - 14:39 -
Canada House Wellness Group Continues Strategic Transformation with the Hiring of Alex Kroon and Steven Pearce and Announces Issuance of Stock Options
20/07/2018 - 14:35 -
SELLAS Receives Fast Track Designation from FDA for Galinpepimut-S for the Treatment of Patients with Multiple Myeloma
20/07/2018 - 14:30 -
Maple Leaf Green World upgrades to OTCQX Best Markets
20/07/2018 - 14:30 -
Sarepta Therapeutics to Announce Second Quarter 2018 Financial Results and Recent Corporate Developments on August 8, 2018
20/07/2018 - 14:30 -
APHL Receives $7.5 Million Award to Strengthen Newborn Screening Systems
20/07/2018 - 14:11 -
David Yorio, DO is Appointed to the American Health Council’s Board of Physicians
20/07/2018 - 14:00 -
Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI)
20/07/2018 - 14:00 -
Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board
20/07/2018 - 12:00 -
HSR Act Waiting Period Terminated for United Therapeutics’ Acquisition of SteadyMed Ltd.
20/07/2018 - 12:00 -
BeiGene Attends Hearing Before the Listing Committee of the Stock Exchange of Hong Kong Limited
20/07/2018 - 10:47 -
Shire plc : Rule 2.9 Announcement
20/07/2018 - 08:01
Pages